Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria
- PMID: 10602746
- PMCID: PMC89651
- DOI: 10.1128/AAC.44.1.186-189.2000
Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria
Abstract
The postantibiotic effect (PAE) (10x the MIC) and the postantibiotic sub-MIC effects (0.125, 0.25, and 0.5x the MIC) were determined for six compounds against 12 strains. Measurable PAEs ranged between 0 and 1.8 h for grepafloxacin, 0 and 2.2 h for ciprofloxacin, 0 and 3. 1 h for levofloxacin, 0 and 2.2 h for sparfloxacin, 0 and 2.4 h for amoxicillin-clavulanate and 0 and 4.8 h for clarithromycin. Reexposure to subinhibitory concentrations increased the PAEs against some strains.
Similar articles
-
Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria.J Antimicrob Chemother. 2000 Jul;46(1):35-43. doi: 10.1093/jac/46.1.35. J Antimicrob Chemother. 2000. PMID: 10882686
-
Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.Antimicrob Agents Chemother. 1998 Jun;42(6):1503-5. doi: 10.1128/AAC.42.6.1503. Antimicrob Agents Chemother. 1998. PMID: 9624503 Free PMC article.
-
Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.Antimicrob Agents Chemother. 2000 Mar;44(3):633-9. doi: 10.1128/AAC.44.3.633-639.2000. Antimicrob Agents Chemother. 2000. PMID: 10681330 Free PMC article.
-
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.J Antimicrob Chemother. 1999 May;43 Suppl B:1-11. doi: 10.1093/jac/43.suppl_2.1. J Antimicrob Chemother. 1999. PMID: 10382869 Review.
-
Expanded activity and utility of the new fluoroquinolones: a review.Clin Ther. 1999 Jan;21(1):3-40; discussion 1-2. doi: 10.1016/s0149-2918(00)88266-1. Clin Ther. 1999. PMID: 10090423 Review.
Cited by
-
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.Antimicrob Agents Chemother. 2015 Jan;59(1):467-74. doi: 10.1128/AAC.04124-14. Epub 2014 Nov 10. Antimicrob Agents Chemother. 2015. PMID: 25385112 Free PMC article.
-
Translating slow-binding inhibition kinetics into cellular and in vivo effects.Nat Chem Biol. 2015 Jun;11(6):416-23. doi: 10.1038/nchembio.1796. Epub 2015 Apr 20. Nat Chem Biol. 2015. PMID: 25894085 Free PMC article.
-
Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.PLoS One. 2020 Nov 3;15(11):e0241780. doi: 10.1371/journal.pone.0241780. eCollection 2020. PLoS One. 2020. PMID: 33141832 Free PMC article.
-
Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.PLoS One. 2020 Feb 19;15(2):e0228509. doi: 10.1371/journal.pone.0228509. eCollection 2020. PLoS One. 2020. PMID: 32074119 Free PMC article.
-
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.Drugs. 2003;63(24):2769-802. doi: 10.2165/00003495-200363240-00008. Drugs. 2003. PMID: 14664657 Review.
References
-
- Cook P J, Andrews J M, Wise R, Honeybourne D, Moudgil H. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments. J Antimicrob Chemother. 1995;35:317–326. - PubMed
-
- Craig W A, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore, Md: The Williams & Wilkins Co.; 1996. pp. 296–329.
-
- Doern G V, Brueggeman A, Holley H P, Jr, Rauch A M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208–1213. - PMC - PubMed
-
- Doern G V, Brueggeman A B, Pierce G, Holley H P, Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292–297. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources